Cinven Acquires Amdipharm Group

European private equity firm Cinven has acquired the Amdipharm Group, a family-owned international niche pharmaceuticals business, for a total consideration of 367 million pounds ($589.5 million). Amdipharm will initially operate as a standalone business but Cinven will be looking to merge Amdipharm with its existing portfolio company, Mercury Pharma, which it acquired in September 2012.

DealsNorth AmericaUSBriefs